Side-by-side comparison of AI visibility scores, market position, and capabilities
UDR Inc. (UDR) reported ~$1.6B revenue in FY2024. Apartment REIT owning 59,000+ units in high-growth coastal and Sunbelt markets with focus on value-add development. HQ: Highlands Ranch, CO.
UDR, Inc. is a multifamily real estate investment trust that owns, acquires, develops, and manages apartment communities across the United States. Founded in 1972, UDR owns or has interests in approximately 59,000 apartment homes across 20+ markets, with a portfolio balanced between high-cost coastal markets (Boston, Washington D.C., New York, Southern California, San Francisco) and growing Sunbelt metros (Nashville, Tampa, Denver, Austin). The company is known for its "next generation" amenity-rich communities and tech-enabled property management.
Denver healthcare REIT (NYSE: DOC) $21B combined; Healthpeak + Physicians Realty Trust merger Mar 2024, life science labs (SF/SD/Boston) + 300+ MOBs, competing with Alexandria Real Estate and Ventas.
Healthpeak Properties, Inc. is a Denver, Colorado-based healthcare real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: DOC) as an S&P 500 Real Estate component — owning, operating, and developing healthcare-focused real estate including life science laboratory buildings (biopharmaceutical R&D facilities in South San Francisco, San Diego, Boston), medical office buildings (outpatient care facilities adjacent to major hospital campuses), and continuing care retirement communities through approximately 400 employees. In March 2024, Healthpeak Properties (then trading as HCP/PEAK) completed its $21 billion merger of equals with Physicians Realty Trust (DOC — medical office REIT with 300+ medical outpatient buildings in 30+ states) — adopting Physicians Realty Trust's ticker symbol "DOC" and creating a $21 billion combined healthcare REIT with 60+ million square feet of life science labs, 18+ million square feet of medical office, and the most diversified healthcare real estate portfolio among public healthcare REITs. CEO Scott Brinker leads the combined company's strategy of capitalizing on the structural demand drivers for healthcare real estate: life science lab demand driven by NIH funding, private biopharma venture investment, and drug approval tailwinds — and medical office demand driven by the shift of healthcare delivery from hospital inpatient settings to outpatient ambulatory care facilities that require real estate closer to patient populations. Healthpeak's life science portfolio in the three dominant biotech clusters (San Francisco Bay Area, San Diego's Torrey Pines/UTC corridor, Boston's Kendall Square/Route 128 corridor) positions it in the markets where biopharma and biotech tenants require Class A laboratory space for drug discovery and development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.